Open access
Open access
Powered by Google Translator Translator

Infectious Diseases (All Articles)

M-A: Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing

20 Apr, 2021 | 06:09h | UTC

Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis – The Lancet Infectious Diseases

Commentary: Beyond COVID-19—will self-sampling and testing become the norm? – The Lancet Infectious Diseases

Related Meta-analysis: Saliva and nasopharyngeal swab nucleic acid amplification have similar diagnostic accuracy for the detection of SARS-CoV-2 AND Saliva vs. nasopharyngeal swabs equally sensitive for Covid-19 diagnosis

 


[News release – not published yet] Sputnik V demonstrates 97.6% efficacy according to the analysis of data of 3.8 million vaccinated persons in Russia

20 Apr, 2021 | 06:08h | UTC

Sputnik V demonstrates 97.6% efficacy according to the analysis of data of 3.8 million vaccinated persons in Russia

 

Commentary on Twitter

 


COVID-19 dynamics after a national immunization program in Israel

20 Apr, 2021 | 06:06h | UTC

COVID-19 dynamics after a national immunization program in Israel – Nature Medicine

 

Commentary on Twitter

 


Large cohort finds low risk of SARS-CoV-2 cardiac involvement in young competitive athletes

20 Apr, 2021 | 06:04h | UTC

SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes – Circulation

News Release: Study: Heart setbacks from COVID-19 unlikely in athletes – UW Medicine

 


UK researchers will deliberately reinfect people with COVID-19 in new ‘challenge study’

20 Apr, 2021 | 06:03h | UTC

UK researchers will deliberately reinfect people with COVID-19 in new ‘challenge study’ – LiveScience

See also: Young people to be reinfected with Covid for study – BBC

 


Pfizer CEO says third Covid vaccine dose likely needed within 12 months

20 Apr, 2021 | 06:02h | UTC

Pfizer CEO says third Covid vaccine dose likely needed within 12 months – CNBC

Commentary: Fully Vaccinated? Get Ready For Your Third Dose – Forbes

 


M-A: Prevalence of depression, anxiety and post-traumatic stress disorder in health care workers during the COVID-19 pandemic

20 Apr, 2021 | 06:00h | UTC

Prevalence of depression, anxiety and post-traumatic stress disorder in health care workers during the COVID-19 pandemic: A systematic review and meta-analysis – PLOS One

 


Ten scientific reasons in support of airborne transmission of SARS-CoV-2

18 Apr, 2021 | 21:51h | UTC

Ten scientific reasons in support of airborne transmission of SARS-CoV-2 – The Lancet

Commentary: Recognising that coronavirus is predominantly spread through air would save lives, argues new assessment – University of Oxford

Animated Videos: Aerosols and making spaces safe – University of Oxford

 

Commentary on Twitter (thread – click for more)

 


Chlamydia and gonorrhea: new recommendation to screen sexually active patients under 30

20 Apr, 2021 | 05:42h | UTC

Guideline: Recommendation on screening for chlamydia and gonorrhea in primary care for individuals not known to be at high risk – Canadian Medical Association Journal

News release: Under 30 and sexually active? It’s a good idea to get tested for chlamydia and gonorrhea – Canadian Task Force on Preventive Health Care

Summary: Chlamydia and gonorrhea: new recommendation to screen sexually active patients under 30 – Canadian Task Force on Preventive Health Care

Related USPSTF Draft Statement: Screening for Chlamydia and Gonorrhea – U.S. Preventive Services Task Force

 


RCT: Effect of infusion set replacement intervals on catheter-related bloodstream infections – “Infusion set use can be safely extended to 7 days with resultant cost and workload reductions”

20 Apr, 2021 | 05:37h | UTC

Effect of infusion set replacement intervals on catheter-related bloodstream infections (RSVP): a randomised, controlled, equivalence (central venous access device)–non-inferiority (peripheral arterial catheter) trial – The Lancet (link to abstract – $ for full-text)

 

Commentaries on Twitter

 


RCT: Ravidasvir plus sofosbuvir are effective and well tolerated in patients with chronic HCV infection, with potential as an affordable treatment for these patients

18 Apr, 2021 | 21:19h | UTC

Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial – The Lancet Gastroenterology & Hepatology

 

Commentary on Twitter

 


Indoor Air Changes and Potential Implications for SARS-CoV-2 Transmission

18 Apr, 2021 | 21:49h | UTC

Indoor Air Changes and Potential Implications for SARS-CoV-2 Transmission – JAMA

 

Commentary on Twitter (thread – click for more)

 


A guideline to limit indoor airborne transmission of COVID-19

18 Apr, 2021 | 21:47h | UTC

A guideline to limit indoor airborne transmission of COVID-19 – Proceedings of the National Academy of Sciences

 


China’s Sinovac COVID-19 vaccine 67% effective in preventing symptomatic infection, 85% effective in preventing hospitalizations and 80% effective in preventing deaths – Chile govt report

18 Apr, 2021 | 21:45h | UTC

China’s Sinovac COVID-19 vaccine 67% effective in preventing symptomatic infection – Chile govt report – Reuters

 

Commentary on Twitter (thread – click for more)

 


Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination

18 Apr, 2021 | 21:43h | UTC

Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination – New England Journal of Medicine

Commentaries: Researchers Offer Algorithm for Managing Thrombosis and Thrombocytopenia After COVID-19 Vaccination – NEJM Journal Watch AND Blood Clots After COVID-19 Vaccination Linked to Immune Response: UK Report – TCTMD AND People with rare blood clots after a COVID-19 jab share an uncommon immune response – ScienceNews

 


Editorial: SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia – “The very low prevalence of this complication of vaccination, however severe, relative to the benefits of preventing Covid-19 must be emphasized”

18 Apr, 2021 | 21:42h | UTC

SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia – New England Journal of Medicine

 


COVID vaccines and blood clots: five key questions

18 Apr, 2021 | 21:40h | UTC

COVID vaccines and blood clots: five key questions – Nature

See also (podcast): Coronapod: could COVID vaccines cause blood clots? Here’s what the science says – Nature

 


Study: Double masking improves protection from Covid-19 mostly by eliminating any gaps or poor-fitting areas of a mask

18 Apr, 2021 | 21:37h | UTC

Fitted Filtration Efficiency of Double Masking During the COVID-19 Pandemic – JAMA Internal Medicine

Commentaries: Fit matters most when double masking to protect yourself from COVID-19 – University of North Carolina Health Care AND Check your fit on that double mask if you want it to work against Covid, study says – CNN

 


Study shows past COVID-19 infection doesn’t fully protect young people against reinfection

18 Apr, 2021 | 21:35h | UTC

Study shows past COVID-19 infection doesn’t fully protect young people against reinfection – Mount Sinai School of Medicine

Original study: SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study – The Lancet Respiratory Medicine

Related Study: SARS-CoV-2 infection rates of antibody-positive vs. antibody-negative health-care workers – previous infection was associated with 84% lower risk of (re)infection

 

Commentary on Twitter

 


WHO: Benefits of continuing to provide life-saving HIV services outweigh the risk of COVID-19 transmission by 100 to 1

18 Apr, 2021 | 21:32h | UTC

Benefits of continuing to provide life-saving HIV services outweigh the risk of COVID-19 transmission by 100 to 1 – World Health Organization

 


WHO: Global shortage of innovative antibiotics fuels emergence and spread of drug-resistance

16 Apr, 2021 | 06:20h | UTC

News release: Global shortage of innovative antibiotics fuels emergence and spread of drug-resistance – World Health Organization

Report: 2020 antibacterial agents in clinical and preclinical development: an overview and analysis – World Health Organization

Commentary: WHO report highlights shortage of new antibiotics – CIDRAP

 


[Preprint] Risk of rare blood clotting much higher for COVID-19 than for vaccines

16 Apr, 2021 | 06:37h | UTC

News release: Risk of rare blood clotting higher for COVID-19 than for vaccines – University of Oxford

Original study (preprint): Cerebral venous thrombosis: a retrospective cohort study of 513,284 confirmed COVID-19 cases and a comparison with 489,871 people receiving a COVID-19 mRNA vaccine

Commentaries: Brain clots ‘more likely’ with Covid infection than vaccine – BBC AND Risk for Cerebral Venous Thrombosis Elevated After COVID-19 Diagnosis – NEJM Journal Watch AND Study: COVID much more likely than vaccines to cause blood clots – CIDRAP

 

Commentary on Twitter

 


Evolving changes in mortality of 13,301 critically ill adult patients with COVID-19 over 8 months

16 Apr, 2021 | 06:35h | UTC

Evolving changes in mortality of 13,301 critically ill adult patients with COVID-19 over 8 months – Intensive Care Medicine

 

Commentary on Twitter

 


CDC study suggests leaving middle seat empty could lower COVID-19 spread on planes by 23% to 57%

16 Apr, 2021 | 06:33h | UTC

Laboratory Modeling of SARS-CoV-2 Exposure Reduction Through Physically Distanced Seating in Aircraft Cabins Using Bacteriophage Aerosol — November 2020 – CDC Morbidity and Mortality Weekly Report

Commentaries: Keeping middle seats vacant on airplanes can reduce risk of Covid-19 exposure by up to 57%, CDC study says – CNN AND Leaving middle seat empty lowers COVID-19 spread on planes, modeling suggests – LiveScience

 


Video | Coronavirus variants: What you need to know

16 Apr, 2021 | 06:32h | UTC

Coronavirus variants: What you need to know – Nature Video

 


Stay Updated in Your Specialty

No spam, just news.